Host cell lines for production of antibody constant region with enhanced effector function

A technology of cell lines, hybridoma cell lines, applied in the field of host cell lines for the production of antibody constant regions with enhanced effector functions, capable of solving problems such as slow growth, unadapted growth, poor production, etc.

Inactive Publication Date: 2010-01-13
CENTOCOR
View PDF15 Cites 5 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The disadvantage of CD medium is that most production cell lines

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Host cell lines for production of antibody constant region with enhanced effector function
  • Host cell lines for production of antibody constant region with enhanced effector function
  • Host cell lines for production of antibody constant region with enhanced effector function

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0096] Example 1: Adaptation and cloning of the APF-YB2 / 0 cell line

[0097] The rat hybridoma cell line YB2 / 0 (C1083A) cultured in DMEM supplemented with 5% FBS (DMEM+5% FBS) was cultured in APF medium CD-Hyb, CD-Hybridoma (Gibco) by two different methods Adapt to growth:

[0098] method 1 The cells were slowly weaned from the FBS-containing medium by repeated passaging 1:1 in CD-Hyb medium supplemented with 6 mM glutamine. After 6 passages, cells were able to grow in APF medium. This cell line is called C1083B (Table I). The growth characteristics of C1083B in CD-Hyb and DMEM+5%FBS were comparable ( image 3 ). Single clones were isolated from C1083B by limiting dilution using DMEM+5% FBS. 24 clones were transferred for scale-up and 8 clones from this experiment were selected for further study. Selection criteria for these 8 clones included mean doubling time (MDT), ability to achieve high cell densities in shake flask cultures, and stability over multiple passages. ...

Embodiment 2

[0103] Example 2: Isolation of YB2 / 0 clones resistant to fucose-specific lectins

[0104] Lectins can be used to select cell lines expressing specific types of oligosaccharides (Ripka and Stanley, 1986. Somatic Cell Mol Gen 12:51-62). Of the two fucose-specific lectins available, lentil agglutinin (LCA) was chosen using C1083B to generate a killing curve (in the form of a strip graph) ( Figure 5 ). C1083B cells (cultured in DMEM+5% FBS) were plated in 96-well plates at 5000 cells / well in the presence of various concentrations of LCA lectin. After 5 days, variability was determined by the Alamar Blue assay (Vybrant Cell Metabolism Assay Kit, Molecular Probes, Inc.).

[0105] Rare natural variants of C1083B expressing reduced levels of fut8 mRNA (SEQ ID NO: 1 ) were selected for by plating 5 cells / well in 96-well plates in the presence of 50 μg / ml LCA. After 3 weeks, (2×10 4 cells) and 17 resistant clones were identified. These clones were expanded and passaged several tim...

Embodiment 3

[0107] Example 3: Transfection of C1083B cells with anti-tissue factor antibody DNA

[0108] The anti-human tissue factor antibody CNTO 860 was chosen because its efficacy in reducing or preventing tumor growth tested in a human xenograft cancer model in mice was dependent on ADCC activity. Further described in WO / 04110363, expression vectors p2401 and p2402 encoding CNTO 860 heavy and light chains (as described in Figure 8 shown in ) and US Patent Application Serial No. 11 / 010,797) were co-transfected with pSV2DHFR (Promega), and clones against the selection marker MHX (mycophenolic acid, hypoxanthine, and xanthine) were analyzed for antibody expression by ELISA. A high expression cell line C1261A was selected for further research. It produced 45-50 mg / L in CD-Hyb medium in shake flask cultures, indicating stability of expression over multiple passages ( Figure 9 ). Growth and antibody titers were monitored without and with 1x Lipid (Gibco).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

Host cell lines for biopharmaceutical production of antibodies, antibody fragments or antibody-derived fusion proteins are selected as having the capability of inducing improved cellular effector functions, e.g., Fc-medicated effector functions. The host cells are derived from the rat myeloma cell line YB2/0 and are adapted to growth in chemically-defined medium.

Description

field of invention [0001] The present invention relates to cells, cell lines and cell cultures useful in recombinant DNA techniques and for the production of proteins in cell culture. More specifically, the invention relates to clonal myeloma cell lines capable of growth in chemically defined media that provide enhanced antibody effector function. Background of the invention [0002] Antibodies are often referred to as adapter molecules involved in the mechanisms of humoral and cellular immunity: the humoral response is largely due to mature, secreted circulating antibodies capable of binding target antigens with high affinity, defined by the variable region inherent specificity endowment. Cellular responses are attributed to the consequences of cellular activation through binding of antibody-antigen (ab-ag) complexes and downstream post-events resulting from the release of cellular mediators due to binding of the ab-ag complexes to effector cells. These cellular responses...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12N5/06C07K16/00C12P21/08C12P21/04A61K39/395A61K39/40C07K17/00
Inventor H·多赖Y·S·孔B·斯卡伦
Owner CENTOCOR
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap